Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Tesamorelin Acetate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Theratechnologies Warns Of Egrifta Supply Disruption After Plant Shutdown
    Theratechnologies Warns Of Egrifta Supply Disruption After Plant Shutdown

    18 Sep 2024

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/theratechnologies-warns-hiv-med-disruption-after-third-party-plant-shutdown

    FIERCE PHARMA
    18 Sep 2024
    Share Share
    Theratechnologies Announces Risk of EGRIFTA SV® Supply Disruption
    Theratechnologies Announces Risk of EGRIFTA SV® Supply Disruption

    17 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/17/2947862/0/en/Theratechnologies-Announces-a-Risk-of-a-Temporary-Supply-Disruption-for-EGRIFTA-SV-in-Early-2025.html

    GLOBENEWSWIRE
    17 Sep 2024
    Share Share
    FDA declines to approve new form of HIV-associated lipodystrophy drug
    FDA declines to approve new form of HIV-associated lipodystrophy drug

    25 Jan 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/01/24/2815109/0/en/Theratechnologies-Receives-Complete-Response-Letter-CRL-from-the-FDA-for-the-F8-Formulation-of-Tesamorelin-sBLA.html

    GLOBENEWSWIRE
    25 Jan 2024
    Share Share
    Theratechnologies Receives Update from FDA on Tesamorelin F8 sBLA
    Theratechnologies Receives Update from FDA on Tesamorelin F8 sBLA

    23 Jan 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/01/23/2813983/0/en/Theratechnologies-Receives-Update-from-FDA-on-Tesamorelin-F8-Supplemental-Biologic-License-Application.html

    GLOBENEWSWIRE
    23 Jan 2024
    Share Share
    Theratechnologies Receives January 2024 PDUFA Goal Date for Tesamorelin
    Theratechnologies Receives January 2024 PDUFA Goal Date for Tesamorelin

    04 Oct 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/10/04/2754473/0/en/Theratechnologies-Receives-January-2024-PDUFA-Goal-Date-for-Tesamorelin-F8-Formulation-sBLA.html

    GLOBENEWSWIRE
    04 Oct 2023
    Share Share
    Theratechnologies Announces That Data On The Mechanism Of Effect Of Tesamorelin
    Theratechnologies Announces That Data On The Mechanism Of Effect Of Tesamorelin

    06 Nov 2020

    // THERATECH

    https://www.theratech.com/en/theratechnologies-announces-that-data-on-the-mechanism-of-effect-of-tesamorelin-in-nafld-will-be-presented-at-the-liver-meeting-2020/

    THERATECH
    06 Nov 2020
    Share Share